Press Releases 27 Sep '2022 Context Therapeutics® Amends Cash Guidance, Extends Runway into Q1 2024 06 Sep '2022 Context Therapeutics® to Participate in the H.C. Wainwright 24th Annual Global Investment Conference 11 Aug '2022 Context Therapeutics® Reports Second Quarter 2022 Operating and Financial Results 02 Aug '2022 Context Therapeutics and The Menarini Group Announce Clinical Trial Collaboration and Supply Agreement to Evaluate ONA-XR and Elacestrant Combination View All News View All
06 Sep '2022 Context Therapeutics® to Participate in the H.C. Wainwright 24th Annual Global Investment Conference
02 Aug '2022 Context Therapeutics and The Menarini Group Announce Clinical Trial Collaboration and Supply Agreement to Evaluate ONA-XR and Elacestrant Combination
